UK study tests newborn screening for rare muscle disease

NCT ID NCT05481164

Completed Knowledge-focused Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at whether it is practical and acceptable to screen all newborns for spinal muscular atrophy (SMA), a rare genetic disease that causes muscle weakness and can be fatal if not treated early. Over 33,000 babies were screened using a simple blood spot test. The goal was to see how many parents agreed to screening and how reliable the test was, with the hope that early detection could lead to better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could pave the way for nationwide newborn screening for SMA, allowing early diagnosis and treatment before symptoms appear.
What could go wrong: This is a feasibility study, not a treatment trial. It only measures uptake and accuracy of screening, not long-term health outcomes. Results may not apply outside the UK.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCULAR ATROPHY, SPINAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal muscular atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MUSCULAR ATROPHY, SPINAL

Contacts and locations

Locations

Buckinghamshire HealthCare Trust

Buckingham, United Kingdom
Dorset County Hospital (DCHFT)

Dorchester, DT1 2JY, United Kingdom
Milton Keynes University Hospital NHS Foundation Trust

Milton Keynes, United Kingdom
Princess Anne Hospital

Southampton, United Kingdom
Queen Alexandra Hospital

Portsmouth, United Kingdom
Royal Berkshire NHS Foundation Trust

Reading, United Kingdom
Salisbury District Hospital

Salisbury, United Kingdom
St Mary's Maternity Hospital

Poole, United Kingdom
University of Oxford UK

Oxford, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.